February 2011 - Page 10 of 25

WednesdayFeb 16, 2011 10:48 am

Simulated Environment Concepts (SMEV.PK) Flagship Product Gains Wider Acceptance in Middle East after Arab Health Convention

Simulated Environment Concepts, the manufacturer and developer of medical, aesthetic, weight loss, wellness, and slimming equipment, today announced further penetration into the Middle East market on the heels of a positive exposition at the Arab Health Dubai International Convention. "We were confident that our SpaCapsule would perform well at the Arab Health Convention and we were very pleased with the positive results reported," commented Dr. Ilya Spivak, Marketing Director and Co-Inventor of the SpaCapsule. "We were however, even more delighted by orders originating out of Qatar immediately following the convention." Qatar, an Arab Emirate federal state, like most countries in…

WednesdayFeb 16, 2011 10:41 am

Sunvalley Solar, Inc. (SSOL) Announces New Advanced Thin Film Solar Panels

Sunvalley Solar, Inc., the leader in solar power technology and solar system integration, recently announced the promotion of its most efficient and advanced TW-TF series thin film product for the US market. The A-Si thin film module has a better performance rating in high temperatures and lower irradiance conditions than previous models. Not only is the performance on the A-Si thin film modules better, but the expense is much lower than the crystalline silicon PV modules. The previous thin film modules required a larger surface area and expensive racking and BOS systems for installation. The new TW-TF series from Tianwei,…

WednesdayFeb 16, 2011 8:30 am

HyperSolar, Inc. (HYSR.OB) Announces Successful Completion of Prototype Design of their Thin Solar Concentrator

HyperSolar, Inc. announced yesterday that they successfully completed a prototype design of their innovative thin solar concentrator. Mr. Tim Young, Chief Executive Officer of HyperSolar, Inc., commented, “Our ultimate goal is to develop an inexpensive and thin solar concentrator for use in replacing expensive solar cells in conventional flat solar panels. After a year of intense research and development, we are excited to report that we have finally achieved a prototype design that we believe can be refined into a commercial product. While this initial prototype is designed to provide 300 percent light magnification, we are aiming for at least…

WednesdayFeb 16, 2011 8:28 am

WaferGen Biosystems (WGBS.OB) Launches Early-access Program for Genotyping Technology

WaferGen Biosystems Inc., a leading developer of state-of-the-art genomic analysis systems for the life science and pharmaceutical industries, recently announced that it is offering an early-access program for high-throughput Single Nucleotide Polymorphism (SNP) Genotyping through its new SmartChip Real-Time PCR System. The company said it issued the offering in response to consumer demand for increasing speed and needs of genomics researchers. The offering is part of the company’s overall expansion based on the commercial success of its SmartChip System as the company delves into the SNP genotyping market. "SNP Genotyping screening with the SmartChip System opens a new and large…

TuesdayFeb 15, 2011 4:27 pm

B Green Innovations, Inc. (BGNN.OB) Expands Sales Network

Finding meaningful uses for recycled materials is clearly the path our world is taking, and for good reason. Nearly a quarter of a billion tires are discarded each year in the United States alone. Some are burned for fuel and other are exported, but the vast majority, nearly 80 percent, are thrown into landfills, stockpiled, or simply illegally thrown somewhere. Matawan, New Jersey-based B Green Innovations, Inc. has found a practical use for recycling tires and is seeing a gradual increase in sales for its products. As a whole, the Company is focused on the development of solutions to eliminate…

TuesdayFeb 15, 2011 3:44 pm

Spectrum Pharmaceuticals Inc. (SPPI) Reports Unaudited Q4, FY Results and 2011 Product Expectations

Spectrum Pharmaceuticals Inc., a biotechnology company focusing on oncology, today announced preliminary unaudited fourth quarter and fiscal 2010 revenues and anticipations for its products in the upcoming year. The company plans to report its full fourth quarter and fiscal year results in mid-March 2011. For the fourth quarter of 2010, the company’s estimated product revenues increased 500 percent to more than $30 million as compared to approximately $5 million in the fourth quarter of 2009. Fourth quarter total revenues increased 267 percent to more than $33 million compared to approximately $9 million reported in the fourth quarter of last year.…

TuesdayFeb 15, 2011 2:23 pm

BAZI International, Inc. (BAZI.OB) Engages Sales and Marketing Powerhouse Advantage Sales & Marketing to Drive the Nationwide Rollout of its BAZI® Brand Energy Shot

BAZI International, www.drinkbazi.com – the formulators of healthy, energy-packed beverage shots under the BAZI® label, reported engagement of 24-year veteran sales and marketing agency Advantage Sales & Marketing (ASM) today to aid the nationwide expansion of the BAZI brand. The dedication to scientifically formulating the very best and healthiest products, maintaining the utmost in quality ingredients and delivering it all with a great taste that packs a punch, has made BAZI renown the world over among top athletes, including Olympic competitors. With a client list 1,200 names long, including some of the top companies in North America and revenue approaching…

TuesdayFeb 15, 2011 2:19 pm

Pacific Biomarkers (PBMC.OB) Posts Financial Results, Impacted by Broader Drug Development Environment

Pacific Biomarkers Inc., a leading provider of specialized biomarker and contract research services, today announced its operating results for the second quarter and first half of fiscal year 2011, noting industry challenges and the company’s strategy for overcoming them. "Our results for the three months ended December 31, 2010, are a reflection of the challenging drug development environment. While revenue increased from the prior year, gross profit was still short of plan. We remain confident that we are well positioned to execute our strategic plan for continued growth in the specialty laboratory and our biomarker services area," Ron Helm, CEO…

TuesdayFeb 15, 2011 12:30 pm

Pluristem Therapeutics Inc. (PSTI) is “One to Watch”

‏Founded in 2001, Pluristem Therapeutics is a bio-therapeutics company that lists on the NASDAQ Capital Market. The Company is dedicated to the commercialization of non-personalized (allogeneic) cell therapy products for the treatment of several severe degenerative, ischemic, and autoimmune disorders. The (PLacental eXpanded) cell products are stored off-the-shelf, ready-to-use, and require no histocompatibility matching. Pluristem Therapeutics Inc. has made the strategic decision to work only with adult stem cells, purified from the placenta after birth, avoiding ethical and religious controversy. The placental adherent stromal cells (ASCs) are expanded in the Company's proprietary PluriX™ 3D bioreactor system. This system provides a…

TuesdayFeb 15, 2011 11:43 am

Aeolus Pharmaceuticals (AOLS.OB) Appoints Russell Skibsted as Chief Financial Officer

Aeolus Pharmaceuticals is developing a new class of catalytic antioxidant compounds that protect healthy tissue from the damaging effects of radiation. The company's first compound, AEOL 10150, is being developed for oncology uses, in combination with radiation therapy. It is also being developed, with funding from the US government as a medical countermeasure against chemical and radiological weapons. The company today announced the appointment of Russell L. Skibsted as senior vice-president and chief financial officer. Mr. Skibsted is a seasoned executive with over 25 years of experience in finance, acquisitions, partnering, marketing and operations. He has worked with companies of…

Site Search

Company Search

Month: February 2011